MacLaughlinKL, FaubionSS, LongME, PruthiS, CaseyPM. Should the annual pelvic examination go the way of annual cervical cytology?. Womens Health (Lond Engl), 2014; 10:373–384.
3.
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC). U.S. Selected Practice Recommendations for Contraceptive Use, 2013: Adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep, 2013; 62(RR-05):1–60.
4.
HarperC, BalistreriE, BoggessJ, LeonK, DarneyP. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect, 2001; 33:13–18.
5.
StormoAR, CooperCP, HawkinsNA, SaraiyaM. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med, 2012; 54:415–421.
6.
International Agency for Research on Cancer (IARC). IARC handbooks of cancer prevention. Cervix cancer screening. Lyon: International Agency for Research on Cancer Press, 2005. Available at www.iarc.fr/en/publications/pdfs-online/prev/handbook10/index.php Accessed December4, 2014.
7.
HowladerN, NooneAM, KrapchoM, et al., eds. SEER Cancer Statistics Review, 1975–2010. Bethesda, MD: National Cancer Institute, 2013. Available at http://seer.cancer.gov/csr/1975_2010 Accessed January7, 2014.
8.
SaslowD, SolomonD, LawsonHW, et al.American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis, 2012; 16:175–204.
9.
MoyerVA. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med, 2012; 157:900–904.
10.
PadillaLA, RadosevichDM, MiladMP. Accuracy of the pelvic examination in detecting adnexal masses. Obstet Gynecol, 2000; 96:593–598.
11.
PadillaLA, RadosevichDM, MiladMP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynaecol Obstet, 2005; 88:84–88.
12.
UelandFR, DepriestPD, DesimoneCP, et al.The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol, 2005; 99:400–403.
13.
BuysSS, PartridgeE, BlackA, et al.Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA, 2011; 305:2295–2303.
14.
BloomfieldHE, OlsonA, CantorA, et al.Screening pelvic exams in asymptomatic average risk women. VA-ESP project 09-009. Washington, DC: Department of Veterans Affairs, 2013.
15.
MeyersD, WolffT, GregoryK, MarionL, MoyerV, NelsonH, et al.USPSTF recommendations for STI screening. Am Fam Physician, 2008; 77:819–824.
16.
ShaferMA, PantellRH, SchachterJ. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?. Arch Pediatr Adolesc Med, 1999; 153:119–125.
17.
BlakeDR, MaldeisN, BarnesMR, HardickA, QuinnTC, GaydosCA. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis, 2008; 35:649–655.
18.
National Comprehensive Cancer Network (NCCN). The NCCN Clinical Practice Guidelines in oncology (NCCN Guidelines) genetic/familial high-risk assessment: Breast and ovarian (Version 1.2014). Fort Washington, PA: NCCN, 2014 Available at www.nccn.org/professionals/physician_gls/f_guidelines.asp Accessed December11, 2014.
19.
LindorNM, PetersenGM, HadleyDW, et al.Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. JAMA, 2006; 296:1507–1517.
20.
National Cancer Institute (NCI). Diethylstilbetrol (DES) and cancer. Bethesda, MD: NCI, 2011. Available at www.cancer.gov/cancertopics/factsheet/Risk/DES Accessed December4, 2014.
21.
SalaniR, BackesFJ, FungMF, et al.Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol, 2011; 204:466–478.
22.
QaseemA, HumphreyLL, HarrisR, StarkeyM, DenbergTD. Screening pelvic examination in adult women: A clinical practice guideline from the American College of Physicians. Ann Intern Med, 2014; 161:67–72.
23.
OscarssonMG, BenzeinEG, WijmaBE. Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol, 2008; 29:23–31.
24.
AugustoEF, RosaML, CavalcantiSM, OliveiraLH. Barriers to cervical cancer screening in women attending the Family Medical Program in Niteroi, Rio de Janeiro. Arch Gynecol Obstet, 2013; 287:53–58.
